The Commission prevailed at trial this week, securing a favorable verdict after a two week jury trial. The action centered on false statements made by an executive regarding regulatory approvals for the only drug of the company. The agency also …
This Week In Securities Litigation (Week ending May 6, 2016) Read More »
The SEC filed another offering fraud action, a current staple of the agency. This scheme centered on two former executives of a privately held software manufacturer and a marketer who sold investors interests in various private entities they controlled which …
SEC Files Offering Fraud Action Centered on Warrants From Private Firm Read More »
